OncoTargets and Therapy · 2018 · 47 citations · 26 references
MedicineOncologyPathologyBreast OncologyMetastasisMolecular OncologyBreast Cancer OncologyLymph Node MetastasisMalignant NeoplasmsBreast Cancer HistologyBreast Cancer Metastasis To Lymph NodesBreast Cancer Molecular SubtypesBreast Cancer PrognosisClinicopathological CorrelationHistological Grade PrognosisLymph Node Metastasis PrognosisPrognostic Value Of Grade
Purpose: The prognostic value and clinical significance of CD44 variant isoform v6 (CD44v6) in breast cancer remains controversial. Our study aimed to generalize the correlation between CD44v6 expression and clinicopathological features and prognosis in breast cancer by using a meta-analysis. Methods: We performed a comprehensive search of relevant literature from PubMed, Cochrane Database, and EMBASE database that were published before January 2018. The pooled ORs and HRs with 95% CIs were used to estimate the effects. Results: Thirteen articles comprising 1,458 patients were included for analysis. The results revealed that CD44v6 expression was associated with histological grade (overall: OR=1.56, 95% CI [1.06, 2.29], P =0.023; Asian: OR=1.78, 95% CI [1.12, 2.85], P =0.016) and lymph node metastasis (overall: OR=1.96, 95% CI [1.01, 3.78], P =0.046; Asian: OR=2.11, 95% CI [1.00, 4.44], P =0.049). CD44v6 expression was significantly associated with poor prognosis in patients with breast cancer (overall survival: overall: HR=1.55, 95% CI [1.09, 2.22], P =0.015; Asian: HR=2.22, 95% CI [1.34, 3.68], P =0.002). Conclusion: Our meta-analysis demonstrates that CD44v6 is significantly associated with poor prognosis, histological grade, and lymph node metastasis in breast cancer patients, especially among Asian patients. Keywords: CD44v6, breast cancer, prognosis, metastasis, meta-analysis
26
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney, Lesley Stewart, Davina Ghersi et al. · Trials · 2007 · 6.4K citations · Full text
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Ursula Günthert, Martin Hofmann‐Apitius, W. Rudy et al. · Cell · 1991 · 1.7K citations